Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial.
(2014) In Journal of Clinical Oncology 32(23). p.2440-2448- Abstract
- Relative efficacy and toxicity of cyclophosphamide compared with ifosfamide are debatable. The Euro-EWING99-R1 trial asked whether cyclophosphamide may replace ifosfamide in combination with vincristine and dactinomycin (vincristine, dactinomycin, and cyclophosphamide [VAC] v vincristine, dactinomycin, and ifosfamide [VAI]) after an intensive induction chemotherapy containing vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in standard-risk localized disease (NCT00020566).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4583782
- author
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Oncology
- volume
- 32
- issue
- 23
- pages
- 2440 - 2448
- publisher
- American Society of Clinical Oncology
- external identifiers
-
- pmid:24982464
- wos:000340556400011
- scopus:84905851588
- pmid:24982464
- ISSN
- 1527-7755
- DOI
- 10.1200/JCO.2013.54.4833
- language
- English
- LU publication?
- yes
- id
- 496b39c9-c4b9-400d-a255-2efefd50858d (old id 4583782)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24982464?dopt=Abstract
- date added to LUP
- 2016-04-01 10:52:44
- date last changed
- 2022-04-12 18:29:42
@article{496b39c9-c4b9-400d-a255-2efefd50858d, abstract = {{Relative efficacy and toxicity of cyclophosphamide compared with ifosfamide are debatable. The Euro-EWING99-R1 trial asked whether cyclophosphamide may replace ifosfamide in combination with vincristine and dactinomycin (vincristine, dactinomycin, and cyclophosphamide [VAC] v vincristine, dactinomycin, and ifosfamide [VAI]) after an intensive induction chemotherapy containing vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in standard-risk localized disease (NCT00020566).}}, author = {{Le Deley, Marie-Cécile and Paulussen, Michael and Lewis, Ian and Brennan, Bernadette and Ranft, Andreas and Whelan, Jeremy and Le Teuff, Gwénaël and Michon, Jean and Ladenstein, Ruth and Marec-Bérard, Perrine and van den Berg, Henk and Hjorth, Lars and Wheatley, Keith and Judson, Ian and Juergens, Heribert and Craft, Alan and Oberlin, Odile and Dirksen, Uta}}, issn = {{1527-7755}}, language = {{eng}}, number = {{23}}, pages = {{2440--2448}}, publisher = {{American Society of Clinical Oncology}}, series = {{Journal of Clinical Oncology}}, title = {{Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial.}}, url = {{http://dx.doi.org/10.1200/JCO.2013.54.4833}}, doi = {{10.1200/JCO.2013.54.4833}}, volume = {{32}}, year = {{2014}}, }